Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer

被引:38
作者
Gressel, Gregory M. [1 ]
Parkash, Vinita [2 ]
Pal, Lubna [1 ]
机构
[1] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
关键词
Complex atypical endometrial hyperplasia; Early-stage endometrial cancer; Fertility preservation; Progestin therapy; RISK; PROGESTIN; CARCINOMA; WOMEN; CHEMOTHERAPY; PREVENTION; DIAGNOSIS; PATHOLOGY; METFORMIN;
D O I
10.1016/j.ijgo.2015.06.031
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Definitive management with hysterectomy could be appropriate for some patients with endometrial cancer and its precursor lesions, but poses challenges for those desiring future fertility. Objectives: To review risk factors for endometrial hyperplasia/cancer among premenopausal women and discuss management options for fertility preservation. Search strategy: A literature search through the PubMed, Ovid, and Cochrane databases was conducted using the terms "endometrial hyperplasia" and "endometrial cancer," cross-referenced with "fertility preservation." Selection criteria: All articles published in English between January 1, 2000, and January 1, 2015, were considered if they were readily available online. Data collection and analysis: Articles were analyzed and information was synthesized into a comprehensive review. Main results: Chronic anovulation, obesity, polycystic ovarian syndrome, metabolic syndrome, insulin resistance, and type 2 diabetes mellitus must be appreciated as risk factors for endometrial pathology. Providers must exert vigilance in identifying patients at risk and in initiating pre-emptive strategies. Risk reduction with lifestyle modification, weight loss, and glycemic control can improve regression and overall health. Fertility outcomes for these patients are promising, especially with assisted reproductive technology. Conclusions: Conservative management could be appropriate for carefully selected women with complex atypical endometrial hypeiplasia or early-stage endometrial cancer who desire future fertility. (C) 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:234 / 239
页数:6
相关论文
共 46 条
  • [21] Systemic and Local Hormone Therapy for Endometrial Hyperplasia and Early Adenocarcinoma
    Hubbs, Jessica L.
    Saig, Reagan M.
    Abaid, Lisa N.
    Bae-Jump, Victoria L.
    Gehrig, Paola A.
    [J]. OBSTETRICS AND GYNECOLOGY, 2013, 121 (06) : 1172 - 1180
  • [22] Conservative management of young patients with endometrial highly-differentiated adenocarcinoma
    Kalogiannidis, I.
    Agorastos, T.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 31 (01) : 13 - 17
  • [23] Kaunitz AM, 1996, J REPROD MED, V41, P419
  • [24] KISTNER RW, 1959, CANCER-AM CANCER SOC, V12, P1106, DOI 10.1002/1097-0142(195911/12)12:6<1106::AID-CNCR2820120607>3.0.CO
  • [25] 2-M
  • [26] KURMAN RJ, 1985, CANCER-AM CANCER SOC, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO
  • [27] 2-X
  • [28] Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk
    Maxwell, G. L.
    Schildkraut, J. M.
    Calingaert, B.
    Risinger, J. I.
    Dainty, L.
    Marchbanks, P. A.
    Berchuck, A.
    Barrett, J. C.
    Rodriguez, G. C.
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 535 - 540
  • [29] Assessing Endometrial Hyperplasia and Carcinoma Treated With Progestin Therapy
    Mentrikoski, Mark J.
    Shah, Akeesha A.
    Hanley, Krisztina Z.
    Atkins, Kristen A.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (04) : 524 - 534
  • [30] Endometrial intraepithelial neoplasia (EIN): Will it bring order to chaos?
    Mutter, GL
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 76 (03) : 287 - 290